Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Children's Oncology Group
Case Comprehensive Cancer Center
Massachusetts General Hospital
New Approaches to Neuroblastoma Therapy Consortium
Children's Oncology Group
City of Hope Medical Center
St. Jude Children's Research Hospital
Children's Oncology Group
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Albert Einstein College of Medicine
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
New Approaches to Neuroblastoma Therapy Consortium
Children's Hospital Los Angeles
New Approaches to Neuroblastoma Therapy Consortium
Children's Oncology Group
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
St. Anna Kinderkrebsforschung
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
Sarcoma Alliance for Research through Collaboration
Children's Oncology Group
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Children's Oncology Group
City of Hope Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
NYU Langone Health
Memorial Sloan Kettering Cancer Center
NYU Langone Health
Children's Oncology Group
Indiana University
University of California, San Francisco
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)